119 related articles for article (PubMed ID: 3331319)
1. Anticoagulation in patients with valvular heart disease, atrial fibrillation, or both.
Kadish SL; Lazar EJ; Frishman WH
Cardiol Clin; 1987 Nov; 5(4):591-628. PubMed ID: 3331319
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation in valvular heart disease preoperatively and postoperatively.
Bodnar AG; Hutter AM
Cardiovasc Clin; 1984; 14(3):247-64. PubMed ID: 6722854
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
4. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
Gohlke-Bärwolf C
Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
[TBL] [Abstract][Full Text] [Related]
5. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation.
McLeod CJ; Gersh BJ
Arch Intern Med; 2009 Nov; 169(21):2032-3; author reply 2033. PubMed ID: 19933968
[No Abstract] [Full Text] [Related]
6. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
7. Peri-operative anticoagulant therapy--the case for an uninterrupted dose-adjusted warfarin regimen in the high-risk patient.
Franz RC
S Afr J Surg; 2006 Aug; 44(3):84, 86. PubMed ID: 16958233
[No Abstract] [Full Text] [Related]
8. [Anticoagulant related hemorrhage and thromboembolism after valvular surgery].
Okada K; Eishi K; Nakano K; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kitoh Y
Kyobu Geka; 1996 Mar; 49(3):190-3. PubMed ID: 8709422
[TBL] [Abstract][Full Text] [Related]
9. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
[TBL] [Abstract][Full Text] [Related]
10. Heparin in the prevention and treatment of arterial thromboembolism.
Verstraete M
Adv Exp Med Biol; 1992; 313():249-58. PubMed ID: 1442264
[No Abstract] [Full Text] [Related]
11. Periprocedural management of anticoagulation in patients on extended warfarin therapy.
Jafri SM; Mehta TP
Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses.
Rothlin ME
Z Kardiol; 1986; 75 Suppl 2():317-20. PubMed ID: 3727710
[No Abstract] [Full Text] [Related]
13. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
14. Left atrial appendage exclusion and the risk of thromboembolic events following mitral valve surgery.
Almahameed ST; Khan M; Zuzek RW; Juratli N; Belden WA; Asher CR; Novaro GM; Martin DO; Natale A
J Cardiovasc Electrophysiol; 2007 Apr; 18(4):364-6. PubMed ID: 17286567
[TBL] [Abstract][Full Text] [Related]
15. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
[TBL] [Abstract][Full Text] [Related]
16. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
17. Major hepatic resection in patients with a prosthetic heart valve receiving anticoagulation treatment.
Shimada M; Matsumata T; Taketomi A; Nishizaki T; Itasaka H; Sugimachi K
Hepatogastroenterology; 1994 Jun; 41(3):290-3. PubMed ID: 7959557
[TBL] [Abstract][Full Text] [Related]
18. [Heart disease, anticoagulants and pregnancy].
Salazar E; Izaguirre R
Rev Esp Cardiol; 2001; 54 Suppl 1():8-16. PubMed ID: 11535183
[TBL] [Abstract][Full Text] [Related]
19. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
Gohlke-Bärwolf C
Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
[TBL] [Abstract][Full Text] [Related]
20. Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice.
Boulanger L; Kim J; Friedman M; Hauch O; Foster T; Menzin J
Int J Clin Pract; 2006 Mar; 60(3):258-64. PubMed ID: 16494639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
